Ellsworth Advisors, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Ellsworth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$38.65 - $43.48 $201,984 - $227,226	5,226 Added 6.44%	86,391 $3.46 Million
Q1 2024 Apr 15, 2024	BUY	$42.85 - $63.45 $3.48 Million - $5.15 Million	81,165 New	81,165 $3.56 Million
Q1 2021 Apr 21, 2021	SELL	$17.21 - $20.65 $177,176 - $212,591	-10,295 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$17.76 - $21.24 $182,839 - $218,665	10,295 New	10,295 $207,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Ellsworth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellsworth Advisors, LLC with notifications on news.